Drug Survival of Biological Therapies for Psoriasis Treatment in Germany and Associated Costs: A Retrospective Claims Database Analysis.

Affiliation

Health Economics and Outcomes Research, Janssen-Cilag, Neuss, Germany. [Email]

Abstract

Our aim was to study drug survival and associated costs of biologic treatment in a German real-world cohort of biologic-naïve psoriasis patients.

Keywords

Biologic therapy,Claims database,Costs,Dermatology,Drug survival,Persistence,Psoriasis,Real-world data,Ustekinumab,